Shandong Pharmaceutical Glass Co Ltd Cash Flow-to-Debt Ratio
Shandong Pharmaceutical Glass Co Ltd cash flow-to-debt ratio. Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of CN¥41.46 Million could theoretically repay 0% of its total liabilities (CN¥1.75 Billion) in one year. Check Shandong Pharmaceutical Glass Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Cash flow-to-debt ratio of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. Historical debt coverage capacity for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. Check Shandong Pharmaceutical Glass Co Ltd (600529) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shandong Pharmaceutical Glass Co Ltd Cash Flow-to-Debt Ratio by Year (2001–2025)
Shandong Pharmaceutical Glass Co Ltd cash flow-to-debt ratio by year from 2001 to 2025. Year-by-year debt coverage analysis for Shandong Pharmaceutical Glass Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Shandong Pharmaceutical Glass Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥576.92 Million | CN¥1.75 Billion | ▼ -39.6% |
| 2024 | 0.55x | CN¥1.17 Billion | CN¥2.13 Billion | ▼ -7.0% |
| 2023 | 0.59x | CN¥1.05 Billion | CN¥1.78 Billion | ▲ +324.1% |
| 2022 | 0.14x | CN¥252.44 Million | CN¥1.82 Billion | ▼ -67.9% |
| 2021 | 0.43x | CN¥750.44 Million | CN¥1.74 Billion | ▲ +4.1% |
| 2020 | 0.41x | CN¥566.01 Million | CN¥1.37 Billion | ▼ -9.9% |
| 2019 | 0.46x | CN¥599.05 Million | CN¥1.30 Billion | ▲ +8.4% |
| 2018 | 0.42x | CN¥465.77 Million | CN¥1.10 Billion | ▼ -4.3% |
| 2017 | 0.44x | CN¥411.96 Million | CN¥929.84 Million | ▼ -24.7% |
| 2016 | 0.59x | CN¥506.53 Million | CN¥860.62 Million | ▲ +11.1% |
| 2015 | 0.53x | CN¥389.63 Million | CN¥735.61 Million | ▲ +37.6% |
| 2014 | 0.38x | CN¥266.63 Million | CN¥692.56 Million | ▼ -3.2% |
| 2013 | 0.40x | CN¥268.60 Million | CN¥675.48 Million | ▲ +836.7% |
| 2012 | 0.04x | CN¥28.52 Million | CN¥671.80 Million | ▼ -90.0% |
| 2011 | 0.43x | CN¥274.63 Million | CN¥644.80 Million | ▲ +52.8% |
| 2010 | 0.28x | CN¥217.01 Million | CN¥778.34 Million | ▼ -30.3% |
| 2009 | 0.40x | CN¥249.27 Million | CN¥623.51 Million | ▲ +132.9% |
| 2008 | 0.17x | CN¥91.76 Million | CN¥534.52 Million | ▼ -21.0% |
| 2007 | 0.22x | CN¥122.63 Million | CN¥564.66 Million | ▲ +95.4% |
| 2006 | 0.11x | CN¥78.47 Million | CN¥705.86 Million | ▲ +42.3% |
| 2005 | 0.08x | CN¥44.09 Million | CN¥564.27 Million | ▲ +1018.5% |
| 2004 | -0.01x | CN¥-3.70 Million | CN¥434.85 Million | ▼ -104.5% |
| 2003 | 0.19x | CN¥59.35 Million | CN¥310.80 Million | ▼ -48.7% |
| 2002 | 0.37x | CN¥109.26 Million | CN¥293.28 Million | ▲ +216.4% |
| 2001 | 0.12x | CN¥28.60 Million | CN¥242.90 Million | — |